Isotretinoin in the treatment of steatocystoma multiplex: a possible adverse reaction.
A patient with steatocystoma multiplex (SM) with severe inflammation was treated with oral isotretinoin. Inflamed cysts markedly improved with treatment. However, after eight weeks of therapy, many pre-existing cysts rapidly enlarged and new cysts occurred. Therapy was then discontinued. Isotretinoin may have exacerbated or worsened this condition.
Rosen
B L
BL
Brodkin
R H
RH
D000328:Adult; D003560:Cysts / Q000139:chemically induced / Q000188:drug therapy*; D005260:Female; D006801:Humans; D015474:Isotretinoin; D012871:Skin Diseases / Q000139:chemically induced / Q000188:drug therapy*; D014212:Tretinoin / Q000009:adverse effects* / Q000627:therapeutic use
D014212:Tretinoin; D015474:Isotretinoin